First positive health technology assessments for novel oral anticoagulant Pradaxa®
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc.
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Nycomed sells oncology programs to 4SC
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128
- Details
- Category: Novo Nordisk
![Novo Nordisk A/S Novo Nordisk A/S](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for DuoCover
- Details
- Category: Bristol-Myers Squibb
![The European Medicines Agency (EMEA) The European Medicines Agency (EMEA)](http://www.worldpharmanews.com/images/stories/logo/emea.gif)
More Pharma News ...
- Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation for DuoPlavin
- Amgen Posts Medical Education and Foundation Grants and Donations
- High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
- A promising start into 2008 for Nycomed
- FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
- First pre-pandemic vaccine approved to help protect against pandemic influenza
- Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent